Adherium Highlights Milestones Achieved in Advance of 2018

By , in PR PR Health on .
SAN MATEO, Calif., Dec. 20, 2017 — Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today highlighted milestones achieved in advance of 2018.
“As we conclude December and the calendar year, we are accelerating realization of our vision of stronger partnerships between patients and physicians, facilitated by easier adherence to the well-designed personal management plans that represent the last mile in healthcare,” said Arik Anderson, CEO of Adherium. “The tragedy of asthma and COPD – where we are focused today – is despite the advances made in therapies, and by physicians who’ve achieved a better understanding of respiratory disease, we are still being held back from sufficiently realizing those gains in patients’ lives.”Asthma continues to be the third-ranking cause of hospitalization for children under 15 years of age in the U.Si. It is the leading cause of missed school days among children 5 to 17ii. Families continue to struggle to cope with asthma, as every missed day of school means missed work. Students with asthma may be at a higher risk of poor performanceiii.“Technology that combines the most clinically-proven precision monitoring with the focused translation of a physician’s guidance into day-to-day care management can bridge the gap that exists today between medical science and the lives we live,” said Anderson.To achieve this, Adherium accomplished a number of key milestones ahead of 2018, which leaves the company poised to deliver on its promise in the New Year –Granted FDA clearance of the SmartTouch™ sensor for AstraZeneca’s Symbicort®Developed next-generation mobile apps and a cloud software platformDeveloped and shipped an enhanced version of the SmartTurbo™ device with additional sensors, allowing more refined management of asthma and COPDSupported AstraZeneca’s ongoing rollout of the SmartTurbo™ device in Europe and an Australian commercial rollout, including to 130 respiratory cliniciansReached over 100,000 devices distributedStrengthened Adherium’s IP portfolio in the U.S.“By the end of our second fiscal quarter, we will have shipped more than 12,500 devices, and I am confident we will achieve or surpass the fiscal year goal of 25,000 devices for the year,” said Anderson.Adherium’s relationship with AstraZeneca has evolved from development to commercialization and Adherium is progressing toward launching the SmartTouchTM device for use with Symbicort in the U.S., following successful distribution in Europe and Australia. A disciplined program is underway to highlight unmet demand in the U.S. via a direct to consumer campaign, expand opportunities with providers and payers to respond to pressure from value-based care requirements, and meet health plan member demands in a volatile and fast-evolving payer market.About AdheriumAdherium is a provider of digital health solutions. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of adherence monitoring sensors for respiratory medications to address sub-optimal medication use and improve health outcomes in chronic disease.Adherium operates globally from bases in the USA, Europe and Australasia.Inquiries
Vik Panda, [email protected]
Chris Gale, [email protected]
Leigh Salvo, [email protected]
Web: www.adherium.com
_______________________iAsthma's Impact on Children and Adolescents. Atlanta: National Center for Environmental Health, Centers for Disease Control and Prevention. (No authors given.) 8 June 2005.
iiAsthma Facts and Figures . Washington: Allergy and Asthma Foundation of America.
iii Taras H, Potts-Datema W. “Childhood Asthma and Student Performance at School.” Journal of School Health, 75(8): 296-312, 2005.
The following two tabs change content below.
Brad Bennett

Brad Bennett

Brad grew up in a small town in northern Iowa. He studied chemistry in college, graduated, and married his wife one month later. They were then blessed with two baby boys within the first four years of marriage. Having babies gave their family a desire to return to the old paths – to nourish their family with traditional, homegrown foods; rid their home of toxic chemicals and petroleum products; and give their boys a chance to know a simple, sustainable way of life. They are currently building a homestead from scratch on two little acres in central Texas. There’s a lot to be done to become somewhat self-sufficient, but they are debt-free and get to spend their days living this simple, good life together with their five young children.
%d bloggers like this: